References
- Kumar R, Maillard I, Schuster SJ, . Utility of fluorodeoxyglucose-PET imaging in the management of patients with Hodgkin's and non-Hodgkin's lymphomas. Radiol Clin North Am 2004;42:1083–1100.
- Cheng G, Servaes S, Alavi A, . FDG PET and PET/CT in the management of pediatric lymphoma patients. PET Clin 2008;3: 621–634.
- Kwee TC, Kwee RM, Nievelstein RA. Imaging in staging of malignant lymphoma: a systematic review. Blood 2008;111:504–516.
- Moskowitz CH, Zelenetz A, Schoder H. An update on the role of interim restaging FDG-PET in patients with diffuse large B-cell lymphoma and Hodgkin lymphoma. J Natl Compr Canc Netw 2010;8:347–352.
- Shankar A, Fiumara F, Pinkerton R. Role of FDG PET in the management of childhood lymphomas—case proven or is the jury still out?Eur J Cancer 2008;44:663–673.
- Cheng G, Alavi A, Zhuang H. Clinical application of FDG PET/CT in pediatric lymphoma patients. PET Clin 2012;7:47–56.
- Hicks RJ, Mac Manus MP, Seymour JF. Initial staging of lymphoma with positron emission tomography and computed tomography. Semin Nucl Med 2005;35:165–175.
- Seam P, Juweid ME, Cheson BD. The role of FDG-PET scans in patients with lymphoma. Blood 2007;110:3507–3516.
- Allen-Auerbach M, de Vos S, Czernin J. The impact of fluorodeoxyglucose-positron emission tomography in primary staging and patient management in lymphoma patients. Radiol Clin North Am 2008;46:199–211.
- Montravers F, McNamara D, Landman-Parker J, . [(18)F]FDG in childhood lymphoma: clinical utility and impact on management. Eur J Nucl Med Mol Imaging 2002;29:1155–1165.
- Hermann S, Wormanns D, Pixberg M, . Staging in childhood lymphoma: differences between FDG-PET and CT. Nucl Med 2005; 44:1–7.
- Hernandez-Pampaloni M, Takalkar A, Yu JQ, . F-18 FDG-PET imaging and correlation with CT in staging and follow-up of pediatric lymphomas. Pediatr Radiol 2006;36:524–531.
- London K, Cross S, Onikul E, . 18F-FDG PET/CT in paediatric lymphoma: comparison with conventional imaging. Eur J Nucl Med Mol Imaging 2011;38:274–284.
- Purz S, Mauz-Korholz C, Korholz D, . [18F]Fluorodeoxyglucose positron emission tomography for detection of bone marrow involvement in children and adolescents with Hodgkin's lymphoma. J Clin Oncol 2011;29:3523–3528.
- Cheng G, Chen W, Chamroonrat W, . Biopsy versus FDG PET/CT in the initial evaluation of bone marrow involvement in pediatric lymphoma patients. Eur J Nucl Med Mol Imaging 2011;38:1469–1476.
- Cheng G, Servaes S, Chamroonrat W, . Non-Hodgkin's lymphoma of the bone and the liver without lymphadenopathy revealed on FDG-PET/CT. Clin Imaging 2010;34:476–479.
- Ribrag V, Vanel D, Leboulleux S, . Prospective study of bone marrow infiltration in aggressive lymphoma by three independent methods: whole-body MRI, PET/CT and bone marrow biopsy. Eur J Radiol 2008;66:325–331.
- Moulin-Romsee G, Hindié E, Cuenca X, . 18F-FDG PET/CT bone/bone marrow findings in Hodgkin's lymphoma may circumvent the use of bone marrow trephine biopsy at diagnosis staging. Eur J Nucl Med Mol Imaging 2010;37:1095–1105.
- Kabickova E, Sumerauer D, Cumlivska E, . Comparison of 18F-FDG-PET and standard procedures for the pretreatment staging of children and adolescents with Hodgkin's disease. Eur J Nucl Med Mol Imaging 2006;33:1025–1031.
- Goethals I, Hoste P, De Vriendt C, . Time-dependent changes in 18F-FDG activity in the thymus and bone marrow following combination chemotherapy in paediatric patients with lymphoma. Eur J Nucl Med Mol Imaging 2010;37:462–467.
- Sugawara Y, Fisher SJ, Zasadny KR, . Preclinical and clinical studies of bone marrow uptake of fluorine-1-fluorodeoxyglucose with or without granulocyte colony-stimulating factor during chemotherapy. J Clin Oncol 1998;16:173–180.